{"id":"https://openalex.org/W2145644454","doi":"https://doi.org/10.1093/jac/dkr445","title":"Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso","display_name":"Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso","publication_year":2011,"publication_date":"2011-10-25","ids":{"openalex":"https://openalex.org/W2145644454","doi":"https://doi.org/10.1093/jac/dkr445","mag":"2145644454","pmid":"https://pubmed.ncbi.nlm.nih.gov/22028201"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkr445","doi":"https://doi.org/10.1093/jac/dkr445","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkr445","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033299612","display_name":"Nuccia Saleri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]},{"id":"https://openalex.org/I79940851","display_name":"University of Brescia","ror":"https://ror.org/02q2d2610","country_code":"IT","type":"education","lineage":["https://openalex.org/I79940851"]}],"countries":["BF","IT"],"is_corresponding":false,"raw_author_name":"N. Saleri","raw_affiliation_strings":["National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso","Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso","institution_ids":["https://openalex.org/I4210131203"]},{"raw_affiliation_string":"Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy","institution_ids":["https://openalex.org/I79940851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041073292","display_name":"Sary Mathurin Demb\u00e9l\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"S. M. Dembele","raw_affiliation_strings":["National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. Villani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Villani","raw_affiliation_strings":["Laboratory of Clinical Pharmacokinetics, IRCCS, San Matteo, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacokinetics, IRCCS, San Matteo, Pavia, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055068464","display_name":"Anna Cristina Cal\u00e7ada Carvalho","orcid":"https://orcid.org/0000-0002-0128-942X","observed_orcids":["https://orcid.org/0000-0002-0128-942X"]},"institutions":[{"id":"https://openalex.org/I79940851","display_name":"University of Brescia","ror":"https://ror.org/02q2d2610","country_code":"IT","type":"education","lineage":["https://openalex.org/I79940851"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. C. C. Carvalho","raw_affiliation_strings":["Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy","institution_ids":["https://openalex.org/I79940851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111966660","display_name":"Maria P. Cusato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Cusato","raw_affiliation_strings":["Laboratory of Clinical Pharmacokinetics, IRCCS, San Matteo, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacokinetics, IRCCS, San Matteo, Pavia, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028503657","display_name":"Victor Bonkoungou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"V. Bonkoungou","raw_affiliation_strings":["National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044437359","display_name":"R. Nacanabo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"R. Nacanabo","raw_affiliation_strings":["National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tuberculosis Program, Ministry of Health, Ouagadougou, Burkina Faso","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004096695","display_name":"S\u00e9ni Kouanda","orcid":"https://orcid.org/0000-0003-2426-7669","observed_orcids":["https://orcid.org/0000-0003-2426-7669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Kouanda","raw_affiliation_strings":["National Research Institute, Ouagadougou, Burkina Faso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Institute, Ouagadougou, Burkina Faso","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084829221","display_name":"Mario Comelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Comelli","raw_affiliation_strings":["Department of Health Sciences, University of Pavia, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences, University of Pavia, Pavia, Italy","institution_ids":["https://openalex.org/I25217355"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108501150","display_name":"Mario Bonora Regazzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Regazzi","raw_affiliation_strings":["Laboratory of Clinical Pharmacokinetics, IRCCS, San Matteo, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacokinetics, IRCCS, San Matteo, Pavia, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005330558","display_name":"Alberto Matteelli","orcid":"https://orcid.org/0000-0001-5109-9248","observed_orcids":["https://orcid.org/0000-0001-5109-9248"]},"institutions":[{"id":"https://openalex.org/I79940851","display_name":"University of Brescia","ror":"https://ror.org/02q2d2610","country_code":"IT","type":"education","lineage":["https://openalex.org/I79940851"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"A. Matteelli","raw_affiliation_strings":["Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy","institution_ids":["https://openalex.org/I79940851"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5005330558"],"corresponding_institution_ids":["https://openalex.org/I79940851"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":0.4411,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.67464445,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"67","issue":"2","first_page":"469","last_page":"472"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.18400000035762787,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.04190000146627426,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.5479999780654907},{"id":"https://openalex.org/keywords/hiv-coinfection","display_name":"HIV coinfection","score":0.8360000252723694},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9459999799728394},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.703000009059906},{"id":"https://openalex.org/keywords/systemic-exposure","display_name":"systemic exposure","score":0.6759999990463257},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7369999885559082},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7429999709129333},{"id":"https://openalex.org/keywords/maximum-concentration","display_name":"maximum concentration","score":0.6150000095367432},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.7409999966621399},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.746999979019165},{"id":"https://openalex.org/keywords/pyrazinamide","display_name":"pyrazinamide","score":0.9710000157356262},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.9890000224113464},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.578000009059906},{"id":"https://openalex.org/keywords/burkina-faso","display_name":"Burkina Faso","score":0.7620000243186951}],"concepts":[{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.8321260213851929},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7718493938446045},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.667486846446991},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.6500104665756226},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6052067279815674},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.4841523766517639},{"id":"https://openalex.org/C3018457394","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral drug","level":5,"score":0.42958569526672363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4272994101047516},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3401023745536804},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.2935897707939148},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.19466185569763184},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09464308619499207}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002050","descriptor_name":"Burkina Faso","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004977","descriptor_name":"Ethambutol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010949","descriptor_name":"Plasma","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011718","descriptor_name":"Pyrazinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1093/jac/dkr445","doi":"https://doi.org/10.1093/jac/dkr445","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkr445","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:22028201","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22028201","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unibs.it:11379/505606","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11379/505606","pdf_url":null,"source":{"id":"https://openalex.org/S4306400804","display_name":"Institutional Research Information System (Universit\u00e0 degli Studi di Brescia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:open-archive.highwire.org:jac:dkr445v1","doi":null,"is_oa":false,"landing_page_url":"http://jac.oxfordjournals.org/cgi/content/short/dkr445v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324342","display_name":"Universit\u00e0 degli Studi di Brescia","ror":"https://ror.org/02q2d2610"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W233147817","https://openalex.org/W1964732626","https://openalex.org/W2009816311","https://openalex.org/W2033925611","https://openalex.org/W2053761650","https://openalex.org/W2061399828","https://openalex.org/W2064213747","https://openalex.org/W2078363932","https://openalex.org/W2097210644","https://openalex.org/W2105010850","https://openalex.org/W2117466548","https://openalex.org/W2120343562","https://openalex.org/W2120761149","https://openalex.org/W2139724863","https://openalex.org/W2147213334","https://openalex.org/W2159369464","https://openalex.org/W2163947037","https://openalex.org/W2169203610","https://openalex.org/W2402563982","https://openalex.org/W2411171235","https://openalex.org/W2416968959","https://openalex.org/W4250696818","https://openalex.org/W4255872969"],"related_works":["https://openalex.org/W2130029003","https://openalex.org/W2413673485","https://openalex.org/W2013015131","https://openalex.org/W1998765853","https://openalex.org/W4412009290","https://openalex.org/W2493897159","https://openalex.org/W3205522338","https://openalex.org/W1481373449","https://openalex.org/W2149786955","https://openalex.org/W2102011808"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Low":[1],"plasma":[2],"concentrations":[3,86],"of":[4,63,75,80,103,116,125,133,140,195,251],"rifampicin,":[5,64],"an":[6],"essential":[7],"antituberculosis":[8],"drug,":[9],"have":[10],"been":[11],"reported":[12],"particularly":[13],"among":[14],"HIV":[15,109,217],"co-infected":[16,49],"persons.":[17],"In":[18],"a":[19,76,247],"prospective,":[20],"longitudinal":[21],"study":[22],"we":[23],"measured":[24],"rifampicin":[25,141,241],"systemic":[26,210],"exposure":[27,211],"at":[28,95,145,157,181,203],"different":[29,97],"timepoints":[30],"during":[31,87,213],"highly":[32],"active":[33],"antiretroviral":[34],"therapy":[35,105,110,118,127],"(HAART).":[36],"PATIENTS":[37],"AND":[38],"METHODS:":[39],"From":[40],"May":[41],"2006":[42],"to":[43,221,237],"April":[44],"2007,":[45],"16":[46],"tuberculosis":[47],"(TB)/HIV":[48],"patients":[50,58],"were":[51,91,175],"enrolled":[52],"in":[53,233],"Ouagadougou,":[54],"Burkina":[55],"Faso.":[56],"All":[57],"received":[59],"fixed":[60,77],"dose":[61,78],"combinations":[62],"isoniazid,":[65],"pyrazinamide":[66],"and":[67,72,83,106,120,154,216],"ethambutol":[68],"under":[69,136],"direct":[70],"observation":[71],"HAART,":[73],"consisting":[74],"combination":[79],"stavudine,":[81],"lamivudine":[82],"nevirapine.":[84],"Rifampicin":[85,209],"the":[88,134,137,178,196,239],"dosing":[89],"interval":[90],"determined":[92],"by":[93,143,155],"HPLC":[94],"three":[96],"timepoints:":[98],"(i)":[99],"after":[100,113,122],"2":[101],"weeks":[102,115,124],"TB":[104,215],"before":[107],"starting":[108],"(T0);":[111],"(ii)":[112],"4":[114],"combined":[117,126,214],"(T1);":[119],"(iii)":[121],"10":[123],"(T2).":[128],"RESULTS:":[129],"The":[130],"median":[131,179],"values":[132],"area":[135],"curve":[138],"(AUC(0-24))":[139],"increased":[142,212,222,249],"39%":[144],"T1":[146],"(15.69":[147],"\u03bcg":[148,160,170],"\u00b7":[149,161,171],"h/mL;":[150,162],"P":[151,163,190],"=":[152,164,191],"0.01)":[153],"83%":[156],"T2":[158,187],"(20.65":[159],"0.001)":[165],"compared":[166,185],"with":[167,186,246],"T0":[168,182,205],"(11.28":[169],"h/mL).":[172],"Similar":[173],"variations":[174],"observed":[176],"for":[177],"C(max)":[180,199,240],"(2.24":[183],"\u03bcg/mL)":[184],"(2.83":[188],"\u03bcg/mL;":[189],"0.003).":[192],"However,":[193],"none":[194],"subjects":[197],"had":[198],"levels":[200],">8":[201],"\u03bcg/mL":[202],"either":[204],"or":[206,225],"T2.":[207],"CONCLUSIONS:":[208],"therapy,":[218],"possibly":[219],"due":[220],"drug":[223],"absorption":[224],"decreased":[226],"oral":[227],"clearance,":[228],"but":[229],"remained":[230],"invariably":[231],"low":[232],"this":[234],"population.":[235],"Studies":[236],"define":[238],"concentrations,":[242],"which":[243],"are":[244,254],"associated":[245],"significantly":[248],"risk":[250],"treatment":[252],"failure,":[253],"urgently":[255],"warranted.":[256]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}